Mark W. Lingen to Risk Assessment
This is a "connection" page, showing publications Mark W. Lingen has written about Risk Assessment.
Connection Strength
0.075
-
Can saliva-based HPV tests establish cancer risk and guide patient management? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Sep; 110(3):273-4.
Score: 0.055
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.020